Semi-automatic decision-making process in histopathological specimens from Barrett's carcinoma patients using hyperspectral imaging (HSI)

3Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Discrimination of malignant and non-malignant cells of histopathologic specimens is a key step in cancer diagnostics. Hyperspectral Imaging (HSI) allows the acquisition of spectra in the visual and near-infrared range (500-1000nm). HSI can support the identification and classification of cancer cells using machine learning algorithms. In this work, we tested four classification methods on histopathological slides of esophageal adenocarcinoma. The best results were achieved with a Multi-Layer Perceptron. Sensitivity and F1-Score values of 90% were obtained.

Cite

CITATION STYLE

APA

Maktabi, M., Köhler, H., Chalopin, C., Neumuth, T., Wichmann, Y., Jansen-Winkeln, B., … Braun, S. (2020). Semi-automatic decision-making process in histopathological specimens from Barrett’s carcinoma patients using hyperspectral imaging (HSI). In Current Directions in Biomedical Engineering (Vol. 6). Walter de Gruyter GmbH. https://doi.org/10.1515/cdbme-2020-3066

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free